The DETAILS BLOG
Capturing Stories from the Field: Reflections, Challenges, & Best Practices
|
By Anna Morgan-Barsamian, MPH, RN, PMP, Senior Manager, Training & Education, NaRCAD An interview with Jennifer Carefoot, BSc, Pharm, Academic Detailing Pharmacist, BC Provincial Academic Detailing (PAD) Service. Tags: Conference, COVID-19, Detailing Visits, Evidence-Based Medicine  Anna: Hi, Jen! Thanks for joining us on DETAILS today. Earlier this year, your team developed a detailing campaign in one week for the new COVID-19 treatment, Paxlovid, and presented on your work at our NaRCAD conference. I’m excited to learn more about this campaign. Before we jump in, can you give us some background about your organization? Jen: The British Columbia Provincial Academic Detailing Service (BC PAD) launched in 2008 and provides academic detailing to the province of British Columbia. We have 12 full-time pharmacist detailers for the entire province. The program is publicly funded by the BC Ministry of Health and our topics are chosen based on their relevance to primary care clinicians. Here are some quick facts about our program:
 Anna: Your team connects with many clinicians covering a vast geographical area! Can you walk us through the one-week development of the Paxlovid campaign that you presented on at our conference? Jen: Paxlovid was approved in Canada on January 17, 2022. The Province of BC quickly received doses and urgently needed educational sessions for clinicians in the province for safe and appropriate use of this somewhat complicated medication. The PAD team had the expertise in delivering pharmacotherapy and education through detailing visits; we worked with the Ministry of Health and the COVID Therapeutics Committee (CTC) to quickly develop materials. We were out in the field detailing within a week! Anna: That’s an impressive turnaround time to get your team prepared and out in the field! Were clinicians aware of Paxlovid when your team started detailing on the topic?  Jen: Paxlovid was getting a lot of press in the media at the time- it was the first oral treatment readily available for COVID-19. Clinicians knew they would have to know about this medication since their patients would be asking about it. Anna: New information was coming out every day in the media, which isn’t very common for other detailing topics. How was your team able to stay up to date on the emerging evidence on Paxlovid and continue to keep clinicians up to date? Jen: Our team was able to stay up to date through the excellent communication between our PAD director, Terryn Naumann, the CTC, and the Ministry of Health. We would receive updates via email or video conference daily. We also frequently met internally to share questions, successes, and challenges that we were experiencing in the field. To keep clinicians up to date, we chose to not provide them with the PowerPoint presentation from the detailing visits because the information and evidence was constantly changing. We’ve created 24 versions to date! Instead, we emailed a one-page resource to clinicians after our visits that included links to online resources that were updated in real time.  Anna: That’s one of the benefits of sharing resources virtually – the information can be updated and accessed quickly. If you were told you had to create another campaign in one week, what would you do differently? Jen: That’s a tough question! Would we have liked more detailers? Yes. Do I wish there were 24 more hours in my day? Yes. Would we have liked more clinical trial data? Yes. These are all things that are outside of our control. We did the best we could with the evidence and resources we had. I don’t know if we would do it any other way if we had to do it again under the same circumstances. Anna: What you did worked. Do you have any evaluation data from clinicians that you can share? Jen: Our formal evaluation showed:
 Anna: I’m not surprised by these results! Your team has shown impressive data from myriad detailing campaigns. Before we wrap up, can you tell us how your partnerships and team helped make this campaign successful? Jen: It’s important to partner with others who have expertise in the therapeutic area you’re detailing on. You don’t need to reinvent the wheel with evidence. Pull from data and evidence that other AD programs or reliable organizations have previously put together and be open to the idea that evidence changes. Also, remember that it really does take a team! Everyone brought something critical and unique to the table. Our administration team was instrumental in getting our visits booked and our director was transparent with our team throughout the process. Our team was excited, enthusiastic, and proud to have the opportunity to provide this education to clinicians in our province. Anna: Having a team that is open to a challenge and eager to stay up to date on evidence is so important. It’s not realistic for programs to have to create a campaign in a week, but if they ever find themselves in that situation, we know we can all turn to you and your team for support! Have thoughts on our DETAILS Blog posts? You can head on over to our Discussion Forum to continue the conversation!  Biography. Jen is an academic detailer for the BC Provincial Academic Service since 2016 serving beautiful South Vancouver Island. She is passionate about translating evidence to practice, reducing polypharmacy and shared decision making. In her spare time, she enjoys running, gardening, travelling, and spending time with her family outdoors at the lake.
Comments are closed.
|